|
|
Volumn 50, Issue 11, 2001, Pages 1385-1386
|
|
Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: An open-label, multicenter study
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTILIPEMIC AGENT;
ATORVASTATIN;
CERIVASTATIN;
CIPROFIBRATE;
FIBRIC ACID DERIVATIVE;
FIBRINOGEN;
GEMFIBROZIL;
HIGH DENSITY LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
MEVINOLIN;
SIMVASTATIN;
TRIACYLGLYCEROL;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL OBSERVATION;
CLINICAL TRIAL;
COMPARATIVE STUDY;
DISEASE CLASSIFICATION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG USE;
DYSLIPIDEMIA;
FIBRINOGEN BLOOD LEVEL;
FOLLOW UP;
HUMAN;
HYPERLIPIDEMIA;
LETTER;
LIPOPROTEIN BLOOD LEVEL;
LONG TERM CARE;
MULTICENTER STUDY;
PRACTICE GUIDELINE;
PRIMARY PREVENTION;
PRIORITY JOURNAL;
SECONDARY PREVENTION;
SIDE EFFECT;
TREATMENT OUTCOME;
|
|
EID: 0035657080
PISSN: 00260495
EISSN: None
Source Type: Journal
DOI: 10.1053/S0026-0495(01)90010-1 Document Type: Letter |
|
Times cited : (3)
|
|
References (0)
|
